肩难产预测机器学习模型的开发与外部验证
研究利用以色列Sheba医学中心和加州大学旧金山医学中心的电子健康记录,开发并外部验证了预测肩难产的机器学习模型。推导队列纳入686例单胎阴道分娩(131例肩难产),验证队列纳入2584例分娩(31例肩难产)。模型在推导队列AUC为0.793±0.041,优于调整估计胎儿体重联合糖尿病(AUC=0.745±0.044,P=1e-16);在验证队列AUC为0.866 vs 0.784(P=0.00007)。在aEFW≥4000g亚组中,模型AUC为0.775,aEFW无预测能力(AUC=0.548)。
要点
- 模型在验证队列预测肩难产AUC为0.866,优于aEFW联合糖尿病(0.784,P=0.00007)。
- 在aEFW≥4000g的273例中,aEFW无预测能力(AUC=0.548),模型AUC为0.775(P=0.0002)。
- 风险评分阈值0.5将42.9%分娩划为高危,涵盖90.9%肩难产病例及全部母儿并发症病例。
核心结论
- 研究开发并外部验证了预测肩难产的机器学习模型,其预测性能优于单独使用估计胎儿体重或联合母体糖尿病。
- 模型能够在疑似巨大儿背景下对肩难产和新生儿损伤风险进行分层。
研究设计与样本
- 研究为机器学习模型开发与外部验证,使用以色列Sheba医学中心电子健康记录作为推导队列,加州大学旧金山医学中心电子健康记录作为验证队列。
- 推导队列纳入686例单胎阴道分娩,其中131例并发肩难产;验证队列纳入2584例分娩,其中31例并发肩难产。
- 收集母儿分娩结局、母体人口学、产科临床数据及超声胎儿生物测量,生物测量及衍生估计胎儿体重按分娩时孕周调整(aEFW)。
- 采用机器学习流程开发模型,推导队列使用嵌套交叉验证评估。
诊断标准与关键数值
- 推导队列中模型AUC为0.793±0.041,优于aEFW联合糖尿病(AUC=0.745±0.044,P=1e-16)。
- 验证队列中模型AUC为0.866,优于aEFW联合糖尿病(AUC=0.784,P=0.00007)。
- 验证队列中aEFW≥4000g亚组(273例)aEFW无预测能力(AUC=0.548),模型AUC为0.775(P=0.0002)。
- 风险评分阈值0.5将42.9%分娩划为高危组,涵盖90.9%肩难产病例及全部伴母体或新生儿并发症病例。
- 更特异阈值0.7将27.5%分娩划为高危组,涵盖63.6%肩难产病例及全部伴新生儿并发症病例。
临床应用与阅片要点
- 模型可用于疑似巨大儿背景下肩难产风险分层,辅助优化剖宫产决策。
- 在aEFW≥4000g亚组中aEFW无预测能力,模型仍具显著预测价值。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To develop a machine-learning (ML) model for prediction of shoulder dystocia (ShD) and to externally validate the model's predictive accuracy and potential clinical efficacy in optimizing the use of Cesarean delivery in the context of suspected macrosomia.
METHODS: We used electronic health records (EHR) from the Sheba Medical Center in Israel to develop the model (derivation cohort) and EHR from the University of California San Francisco Medical Center to validate the model's accuracy and clinical efficacy (validation cohort). Subsequent to application of inclusion and exclusion criteria, the derivation cohort included 686 singleton vaginal deliveries, of which 131 were complicated by ShD, and the validation cohort included 2584 deliveries, of which 31 were complicated by ShD. For each of these deliveries, we collected maternal and neonatal delivery outcomes coupled with maternal demographics, obstetric clinical data and sonographic fetal biometry. Biometric measurements and their derived estimated fetal weight were adjusted (aEFW) according to gestational age at delivery. A ML pipeline was utilized to develop the model.
RESULTS: In the derivation cohort, the ML model provided significantly better prediction than did the current clinical paradigm based on fetal weight and maternal diabetes: using nested cross-validation, the area under the receiver-operating-characteristics curve (AUC) of the model was 0.793 ± 0.041, outperforming aEFW combined with diabetes (AUC = 0.745 ± 0.044, P = 1e-16 ). The following risk modifiers had a positive beta that was > 0.02, i.e. they increased the risk of ShD: aEFW (beta = 0.164), pregestational diabetes (beta = 0.047), prior ShD (beta = 0.04), female fetal sex (beta = 0.04) and adjusted abdominal circumference (beta = 0.03). The following risk modifiers had a negative beta that was < -0.02, i.e. they were protective of ShD: adjusted biparietal diameter (beta = -0.08) and maternal height (beta = -0.03). In the validation cohort, the model outperformed aEFW combined with diabetes (AUC = 0.866 vs 0.784, P = 0.00007). Additionally, in the validation cohort, among the subgroup of 273 women carrying a fetus with aEFW ≥ 4000 g, the aEFW had no predictive power (AUC = 0.548), and the model performed significantly better (0.775, P = 0.0002). A risk-score threshold of 0.5 stratified 42.9% of deliveries to the high-risk group, which included 90.9% of ShD cases and all cases accompanied by maternal or newborn complications. A more specific threshold of 0.7 stratified only 27.5% of the deliveries to the high-risk group, which included 63.6% of ShD cases and all those accompanied by newborn complications.
CONCLUSION: We developed a ML model for prediction of ShD and, in a different cohort, externally validated its performance. The model predicted ShD better than did estimated fetal weight either alone or combined with maternal diabetes, and was able to stratify the risk of ShD and neonatal injury in the context of suspected macrosomia. Copyright © 2019 ISUOG. Published by John Wiley & Sons Ltd.
引用
- Tsur A, Batsry L, Toussia-Cohen S, et al. Development and validation of a machine-learning model for prediction of shoulder dystocia. Ultrasound Obstet Gynecol. 2020. PMID: 31587401. doi:10.1002/uog.21878
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。